On Friday, AbbVie Inc(NYSE:ABBV)’s shares declined -2.92% to $59.76.
Bristol-Myers Squibb Company (BMY) and AbbVie (ABBV) declared the U.S. Food and Drug Administration (FDA) has accepted for preceding review the Biologics License Application (BLA) for Empliciti (elotuzumab), an investigational Signaling Lymphocyte Activation Molecule (SLAMF7)-directed immunostimulatory antibody, for the treatment of multiple myeloma as combination therapy in patients who have received one or more preceding therapies. Empliciti was formerly granted Breakthrough Therapy Designation, which according to the FDA, is intended to expedite the development and review of drugs for serious or life-threatening conditions. The European Medicines Agency (EMA) also recently validated for review the Marketing Authorization Application for Empliciti, granting it accelerated assessment.
Bristol-Myers Squibb has projected the name Empliciti which, if approved by health authorities, will serve as the brand name for elotuzumab.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products comprise HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-oral, short-course, interferon-free therapy, with or without ribavirin, for adult patients with genotype 1 chronic hepatitis, counting those with compensated cirrhosis; Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in people with HIV-1; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1 infection; and Synagis to prevent respiratory syncytial virus infection in high risk infants.
Yamana Gold Inc. (USA) (NYSE:AUY)’s shares dropped -0.58% to $1.72.
BRIO GOLD INC.a partner of Yamana Gold (AUY) (“Yamana” or “the Company”), is hereby announcing the modified process flow sheet and results from the recently accomplished metallurgical testwork at the C1 Santa Luz project (“C1 Santa Luz”), located in the Bahia State of Brazil. The results of the work to date have been incorporated into a Preliminary Economic Assessment Report (“PEA”) in accordance with National Instrument 43-101, which comprises an updated mine design and production plan based on a new mineral resource in connection with the current operating cost estimates and recovery parameters. The PEA is being accomplished by Roscoe Postle Associates Inc (“RPA”).
PEA Results Highlights
- After-tax net present value (“NPV”)(1)at a 5% discount rate of $199 million and an after-tax internal rate of return (“IRR”) of 56%, based on the open pit mineral resource only.
- Average annual gold production of about 100,000 ounces over a ten year mine life, for total open pit life of mine (“LOM”) gold production of 1.03 million ounces of gold.
- Total average LOM recoveries of 83.7%.
- Average LOM all-in sustaining costs(1,2,3)(“AISC”) of $898 per ounce.
- Initial plant capital cost(1)of $27.7 million, plus a $4.9 million contingency.
- Total initial capital cost(1), counting initial plant capital cost, of $47.9 million, counting tailings dam lifts and liner, and community related costs.
Yamana Gold Inc. engages in gold mining and related activities, counting exploration, extraction, processing, and reclamation. The company has precious metal properties and land positions in the Americas. Its portfolio comprises seven operating gold mines, such as Chapada (copper/gold), El Peñón (gold/silver), Canadian Malartic Mine (gold/silver), Jacobina(gold), Gualcamayo(gold), Minera Florida (gold/silver/zinc), Fazenda Brasileiro, and Mercedes (gold/silver), in addition to a 12.5% indirect interest in the Alumbrera mine (copper/gold/molybdenum); and various development stage projects and exploration properties in Brazil, Chile, Argentina, Mexico, and Canada.
At the end of Friday’s trade, Noble Corp plc (NYSE:NE)‘s shares dipped -3.07% to $12.30.
Noble Corporation (NE) declared that David W. Williams, Chairman, President and Chief Executive Officer, Noble Corporation, will present at the Barclays Capital CEO Energy-Power Conference in New York City on Wednesday, September 9, 2015, startning at 8:25 a.m. U.S. Eastern Daylight Time. A live webcast and presentation slides will be accessible at the time of the presentation in the “Investor Relations” section of the Company’s Web site http://www.noblecorp.com. A replay of the presentation will be accessible on our website about three hours after the conclusion of the live presentation and will be accessible for 30 days following the event.
Noble Corporation plc operates as an offshore drilling contractor for the oil and gas industry worldwide. It owns and operates a fleet of mobile offshore drilling units. As of December 31, 2014, the company operated a fleet of 15 jackups, 9 drillships, and 8 semisubmersibles, counting 1 high-specification, harsh environment jackup under construction. Noble Corporation plc was founded in 1921 and is headquartered in London, United Kingdom.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
